• Je něco špatně v tomto záznamu ?

Měření tělesného tuku u chronického onemocnění ledvin - význam pro výzkum a klinickou praxi
[Body fat measurement in chronic kidney disease: implications in research and clinical practice]

Tetsuo Shoji, Eiji Ishimura, Joshiki Nishizawa

Jazyk čeština Země Česko

Perzistentní odkaz   https://www.medvik.cz/link/bmc07506330

The paradoxical and inverse association between body mass index and mortality risk in patients with end-stage renal disease has raised a question of whether an increased fat mass is good or bad for patients with chronic kidney disease. The purpose of this review is to update the concept on body fat in patients with chronic kidney disease. RECENT FINDINGS: A greater fat mass is an independent predictor of better survival in patients on maintenance hemodialysis. Following the initiation of dialysis, chronic kidney disease patients gain body weight due mainly to increased fat mass. Fat mass gain over time predicts better survival in hemodialysis patients. In predialysis chronic kidney disease, there is also an inverse association between body mass index and mortality risk. The metabolic syndrome and a high body mass index are independent predictors for development of chronic kidney disease and end-stage renal disease, respectively. In diabetic patients with chronic kidney disease, however, a high initial body mass index is associated with a slower decline in glomerular filtration rate. SUMMARY: The impacts of fat mass on survival and renal function appear to vary depending upon the absence or presence, and stages of chronic kidney disease. Further research is required for optimal nutritional management and improved outcomes of patients with chronic kidney disease.

Body fat measurement in chronic kidney disease: implications in research and clinical practice

Bibliografie atd.

Lit.: 25

000      
03097naa 2200397 a 4500
001      
bmc07506330
003      
CZ-PrNML
005      
20111210122557.0
008      
080707s2008 xr e cze||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a cze $b eng
044    __
$a xr
100    1_
$a Shoji, Tetsuo
245    10
$a Měření tělesného tuku u chronického onemocnění ledvin - význam pro výzkum a klinickou praxi / $c Tetsuo Shoji, Eiji Ishimura, Joshiki Nishizawa
246    11
$a Body fat measurement in chronic kidney disease: implications in research and clinical practice
314    __
$a Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine, Abeno-ku, Osaka
504    __
$a Lit.: 25
520    9_
$a The paradoxical and inverse association between body mass index and mortality risk in patients with end-stage renal disease has raised a question of whether an increased fat mass is good or bad for patients with chronic kidney disease. The purpose of this review is to update the concept on body fat in patients with chronic kidney disease. RECENT FINDINGS: A greater fat mass is an independent predictor of better survival in patients on maintenance hemodialysis. Following the initiation of dialysis, chronic kidney disease patients gain body weight due mainly to increased fat mass. Fat mass gain over time predicts better survival in hemodialysis patients. In predialysis chronic kidney disease, there is also an inverse association between body mass index and mortality risk. The metabolic syndrome and a high body mass index are independent predictors for development of chronic kidney disease and end-stage renal disease, respectively. In diabetic patients with chronic kidney disease, however, a high initial body mass index is associated with a slower decline in glomerular filtration rate. SUMMARY: The impacts of fat mass on survival and renal function appear to vary depending upon the absence or presence, and stages of chronic kidney disease. Further research is required for optimal nutritional management and improved outcomes of patients with chronic kidney disease.
650    _2
$a tuková tkáň $7 D000273
650    _2
$a antropometrie $7 D000886
650    _2
$a lidé $7 D006801
650    _2
$a chronické selhání ledvin $x mortalita $x patologie $7 D007676
650    _2
$a vyšetření funkce ledvin $7 D007677
650    _2
$a prediktivní hodnota testů $7 D011237
650    _2
$a míra přežití $7 D015996
700    1_
$a Ishimura, Eiji
700    1_
$a Nishizawa, Joshiki
773    0_
$w MED00156014 $t Current opinion in nephrology and hypertension $g Roč. 2, č. 1 (2008), s. 14-18 $x 1802-3827
910    __
$a ABA008 $b B 2490 $c 903 $y 1
990    __
$a 20080707091702 $b ABA008
991    __
$a 20080708084557 $b ABA008
999    __
$a ok $b bmc $g 621955 $s 474388
BAS    __
$a 3
BMC    __
$a 2008 $b 2 $c 1 $d 14-18 $i 1802-3827 $m Current Opinion in Nephrology and Hypertension (České vyd.) $x MED00156014
LZP    __
$a 2008-7/mkme

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...